1Center for Advanced Biotechnology and Medicine, Susan Lehman Cullman Laboratory for Cancer Research, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Cancer Institute of New Jersey, NJ 08854, USA. fangliu@cabm.rutgers.edu
Smad3 protein phosphorylation by CDK4 and CDK2 inhibits its function. This CDK activity in cancer cells may drive tumor growth and resistance to TGF-beta signaling.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: